In the published article, there was an error in Figure 2 as published. In Figures 2C, D, an image was mistakenly duplicated. The corrected Figure 2 and its caption appear below.
FIGURE 2
Effect of nanoparticles on three types of normal cells and three osteosarcoma cell lines. (A) Photoscopic images of three normal cell types (HSFs, ASCs, and BMSCs) treated with 0–50 μg/mL concentrations of nanoparticles. (B) Relative cell viability of three normal cell lines under 0–50 μg/mL concentrations of nanoparticles. (C, E) Photoscopic images and relative cell viability of three kinds of osteosarcoma cells (143b, HOS, and MG63) treated with 0–10 μg/mL concentrations of nanoparticles. (D, F) Photoscopic images and relative cell viability of 143b cells treated with 0–1 μg/mL concentrations of nanoparticles. Scale bar = 100 um.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
nanoparticle, osteosarcoma, zoledronic acid, tumor therapy, targeted therapy
Citation
Xu Y, Qi J, Sun W, Zhong W and Wu H (2025) Corrigendum: Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma. Front. Bioeng. Biotechnol. 13:1601751. doi: 10.3389/fbioe.2025.1601751
Received
28 March 2025
Accepted
24 April 2025
Published
07 May 2025
Volume
13 - 2025
Edited and reviewed by
Jianxun Ding, Chinese Academy of Sciences (CAS), China
Updates
Copyright
© 2025 Xu, Qi, Sun, Zhong and Wu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongwei Wu, wuhongwei@hnca.org.cn
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.